Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud Phenomena”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Large-scale testing (Phase 3)Study completedNCT00351117
What this trial is testing

St. John's Wort in the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Large-scale testing (Phase 3)Study completedNCT01280266
What this trial is testing

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Who this might be right for
Raynaud Phenomenon
Seoul National University Hospital 29
Post-approval studies (Phase 4)Study completedNCT00048763
What this trial is testing

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Testing effectiveness (Phase 2)Study completedNCT04388176
What this trial is testing

Cold Challenge With C21 in RP

Who this might be right for
Raynaud PhenomenonSystemic Sclerosis
Vicore Pharma AB 20
Not applicableLooking for participantsNCT06675344
What this trial is testing

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Who this might be right for
Systemic Sclerosis (SSc)
Robyn T. Domsic, MD, MPH 160
Large-scale testing (Phase 3)UnknownNCT00934427
What this trial is testing

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Who this might be right for
Raynaud Disease
MediQuest Therapeutics 100
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Not applicableEnded earlyNCT03869008
What this trial is testing

Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

Who this might be right for
Raynaud PhenomenonPrimary Raynaud PhenomenonRaynaud Disease+1 more
University of Toledo Health Science Campus 6
Post-approval studies (Phase 4)Looking for participantsNCT05125029
What this trial is testing

Botulinum Toxin in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
Emory University 36
Large-scale testing (Phase 3)Study completedNCT04040322
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 198
Large-scale testing (Phase 3)Study completedNCT01347008
What this trial is testing

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more
Federal University of São Paulo 41
Very early researchStudy completedNCT03027674
What this trial is testing

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Who this might be right for
Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more
Pontificia Universidad Catolica de Chile 10
Testing effectiveness (Phase 2)Study completedNCT00707187
What this trial is testing

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Who this might be right for
Systemic Sclerosis
University of Medicine and Dentistry of New Jersey 120
Not applicableStudy completedNCT04854850
What this trial is testing

Apollo Device for Fatigue in Systemic Sclerosis

Who this might be right for
Systemic SclerosisFatigueRaynaud Phenomenon
Robyn T. Domsic, MD, MPH 25
Testing effectiveness (Phase 2)Study completedNCT00378521
What this trial is testing

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
MediQuest Therapeutics 15
Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Not applicableUnknownNCT03984422
What this trial is testing

Application for Monitoring and Evaluation of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 120
Not applicableWithdrawnNCT03393325
What this trial is testing

Tadalafil-Delivra and Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Not applicableStudy completedNCT00822354
What this trial is testing

Tadalafil for the Treatment of Raynaud's

Who this might be right for
Raynaud
Northwestern University 10
Load More Results